Romoli, Michele http://orcid.org/0000-0001-8009-8543
Sen, Arjune http://orcid.org/0000-0002-8948-4763
Parnetti, Lucilla
Calabresi, Paolo
Costa, Cinzia http://orcid.org/0000-0002-4862-4221
Article History
Accepted: 29 April 2021
First Online: 11 June 2021
Competing interests
: P.C. receives research support from Preston and Zambon to perform preclinical investigation on drugs that are not discussed in the text. A.S. has received research funding, speaker fees and/or honoraria from Bial Limited, Eisai Europe, GW Pharma, Livanova and Eisai. He is lead investigator on the Investigation of Levetiracetam in Alzheimer’s Disease Study (ILiAD), which is currently active but no data are yet available. M.R., C.C. and L.P. declare no competing interests.